Jaminan keamanan dan efektivitas Lepu SARS-CoV-2 Antigen Rapid test
-
2021-06-16
-
LEPU
Klien Yth.,
We are pleased to share with you the most updated news about our Rapid Test SARS-CoV-2 anti gen: Market performance follow-up studies have confirmed the safety and effectiveness of Lepu SARS-CoV-2 Antigen Rapid test.
Untuk terus melacak dan memverifikasi kinerja tes cepat anti gen SARS-CoV-2, teknologi medis LEPU telah melakukan beberapa kinerja pasar post studi di Jerman setelah mendapatkan persetujuan dari peternakan untuk pengujian mandiri.
The post market performance follow-up studies include the performance for layman and professionals respectively. The diagnostic sensitivity was 91.30%, and the specificity was 100% in the study done by Biomex in April 2021. The diagnostic sensitivity was 95.90%, and the specificity was 100% in the study done by Biomex in June 2021. The test results were both acceptable for layman and professionals.
Lepu akan terus menghadirkan produk berkualitas tinggi dan inovatif untuk terus menangani kebutuhan medis global. Silakan beri tahu saya jika ada pertanyaan. Terima kasih!
Hormat kami,
Lepu Medical 
en.lepumedical.com
Follow us on social media
